Akoya Biosciences Inc

NASDAQ:AKYA 4:00:00 PM EDT

2.40

+0.04 (+1.70%)

4:34:12 PM EDT: $2.43 +0.03 (+1.25%)

Market Cap (Intraday)	118.80M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$25.43 Million
Adjusted EPS	-$0.20

See more estimates

10-Day MA	$2.42
50-Day MA	$2.33
200-Day MA	$3.78

See more pivots

Akoya Biosciences Inc Stock, NASDAQ:AKYA

100 Campus Drive, 6th Floor, Marlborough, Massachusetts 01752

United States of America

Phone: +1.855.896.8401

Number of Employees: 330

http://www.akoyabio.com

Description

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.